Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients-Reference-Cited by-同舟云学术

Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients

Published:2021-06-02 Issue:3 Volume:88 Page:439-450
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Sokolenko Anna P.^ORCID,Gorodnova Tatiana V.,Bizin Ilya V.,Kuligina Ekaterina Sh.,Kotiv Khristina B.,Romanko Alexandr A.,Ermachenkova Tatiana I.,Ivantsov Alexandr O.,Preobrazhenskaya Elena V.,Sokolova Tatiana N.,Broyde Robert V.,Imyanitov Evgeny N.

Funder

Russian Science Foundation

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00280-021-04301-6.pdf

Reference27 articles.

1. Cannistra SA (2004) Cancer of the ovary. N Engl J Med 351(24):2519–2529. https://doi.org/10.1056/NEJMra041842

2. Lisio MA, Fu L, Goyeneche A, Gao ZH, Telleria C (2019) High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints. Int J Mol Sci 20(4):952. https://doi.org/10.3390/ijms20040952

3. Gorodnova TV, Sokolenko AP, Kuligina E, Berlev IV, Imyanitov EN (2018) Principles of clinical management of ovarian cancer. Chin Clin Oncol 7(6):56. https://doi.org/10.21037/cco.2018.10.06

4. NCCN Guidelines Version 1.2020 Ovarian Cancer. (2020) Available at: https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf. Accessed 12 Oct 2020

5. Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C; ESMO Guidelines Working Group (2018) Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29(Suppl 4):iv259. https://doi.org/10.1093/annonc/mdt333

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asymptomatic Bloom syndrome diagnosed by chance in a patient with breast cancer;Familial Cancer;2024-09-06

2. HRD-negative high-grade carcinoma of the ovary in <i>BRCA2</i> pathogenic variant carrier;Siberian journal of oncology;2024-05-12

3. Agnostic Administration of Targeted Anticancer Drugs: Looking for a Balance between Hype and Caution;International Journal of Molecular Sciences;2024-04-07

4. Hereditary cancer syndromes;World Journal of Clinical Oncology;2023-02-24

5. Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Breast Cancer Patients;International Journal of Molecular Sciences;2023-01-18